Institut für Tumorbiologie und experimentelle Therapie / Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus

Research facility

Frankfurt am Main, Germany

Publications in cooperation with FAU scientists

Almeida, F.F., Tognarelli, S., Marcais, A., Kueh, A.J., Friede, M.E., Liao, Y.,... Ullrich, E. (2018). A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets. OncoImmunology, 7(10).
Ruder, B., Murtadak, V., Stürzl, M., Wirtz, S., Distler, U., Tenzer, S.,... Becker, C. (2018). Chronic intestinal inflammation in mice expressing viral Flip in epithelial cells. Mucosal Immunology, 11(6), 1621-1629.
Schwab, A., Siddiqui, A., Vazakidou, M.E., Napoli, F., Böttcher, M., Menchicchi, B.,... Ceppi, P. (2018). Polyol pathway links glucose metabolism to the aggressiveness of cancer cells. Cancer Research.
Bocklitz, T.W., Salah, F.S., Vogler, N., Heuke, S., Chernavskaia, O., Schmidt, C.,... Popp, J. (2016). Pseudo-HE images derived from CARS/TPEF/SHG multimodal imaging in combination with Raman-spectroscopy as a pathological screening tool. BMC Cancer, 16(1), 534.
Schwamb, B., Pick, R., Fernandez, S.B.M., Voelp, K., Heering, J., Doetsch, V.,... Zoernig, M. (2015). FAM96A is a novel pro-apoptotic tumor suppressor in gastrointestinal stromal tumors. International Journal of Cancer, 137(6), 1318-29.
Baumgarten, P., Harter, P.N., Toenjes, M., Capper, D., Blank, A.-E., Sahm, F.,... Mittelbronn, M. (2014). Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity. Neuropathology and Applied Neurobiology, 40(2), 205-16.

Last updated on 2017-17-02 at 07:41